fr en es de it pt nl

Reactivos e instrumentos para inmunología, biología celular y biología molecular.

Resultados de su búsqueda : 19 Producto encontrado

Refine su búsqueda :

RUOCE / IVD

Unconjugated 9

Inhibitor/Antagonist/Agonist 14
Other products 5

APLICAR FILTROS
REINICIE

Referencia

Descripción

Cond.

Precio Sin IVA

L2620-30μL

Anti-Neurodegenerative Disease Compound Library

30μL

L2620-1mg

Anti-Neurodegenerative Disease Compound Library

1mg

L2620-100μL

Anti-Neurodegenerative Disease Compound Library

100μL

L2620-50μL

Anti-Neurodegenerative Disease Compound Library

50μL

L2620-250μL

Anti-Neurodegenerative Disease Compound Library

250μL

orb1910676-250mg

COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]

250mg

orb1910676-100mg

COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]

100mg

orb1910676-1g

COH1 is a ribonucleotide reductase (RR) inhibitor. COH1 can be used in research into cancer, mitochondrial diseases, and neurodegenerative diseases. [[20217-22-5]]

1g

orb1910497-250mg

Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]

250mg

orb1910497-1g

Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]

1g

orb1910497-100mg

Pifithrin-β (PFT β hydrobromide; Cyclic Pifithrin-α hydrobromide) is a potent inhibitor of p53 with an IC50 of 23 μM and is regarded as a lead compound for cancer and neurodegenerative disease therapy. [[60477-34-1]]

100mg

orb1910646-1g

ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.

1g

orb1910646-250mg

ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.

250mg

orb1910646-100mg

ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.

100mg

HY-L086-100ul

Neurodegenerative Disease-related Compound Library

100ul

HY-L086-250ul

Neurodegenerative Disease-related Compound Library

250ul

HY-L086-30ul

Neurodegenerative Disease-related Compound Library

30ul

HY-L086-2x100ul

Neurodegenerative Disease-related Compound Library

2x100ul

HY-L086-50ul

Neurodegenerative Disease-related Compound Library

50ul

‹

›